These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 7576219)
1. The dorsal raphe nucleus is a site of action mediating the behavioral effects of the benzodiazepine receptor inverse agonist DMCM. Maier SF; Busch CR; Maswood S; Grahn RE; Watkins LR Behav Neurosci; 1995 Aug; 109(4):759-66. PubMed ID: 7576219 [TBL] [Abstract][Full Text] [Related]
2. Chlordiazepoxide microinjected into the region of the dorsal raphe nucleus eliminates the interference with escape responding produced by inescapable shock whether administered before inescapable shock or escape testing. Maier SF; Kalman BA; Grahn RE Behav Neurosci; 1994 Feb; 108(1):121-30. PubMed ID: 8192838 [TBL] [Abstract][Full Text] [Related]
3. 8-OH-DPAT microinjected in the region of the dorsal raphe nucleus blocks and reverses the enhancement of fear conditioning and interference with escape produced by exposure to inescapable shock. Maier SF; Grahn RE; Watkins LR Behav Neurosci; 1995 Jun; 109(3):404-12. PubMed ID: 7662151 [TBL] [Abstract][Full Text] [Related]
4. The benzodiazepine inverse agonist DMCM as an unconditional stimulus for fear-induced analgesia: implications for the role of GABAA receptors in fear-related behavior. Fanselow MS; Kim JJ Behav Neurosci; 1992 Apr; 106(2):336-44. PubMed ID: 1317186 [TBL] [Abstract][Full Text] [Related]
5. Behavioral evidence for the role of noradrenaline in the putative anxiogenic actions of the inverse benzodiazepine receptor agonist methyl-4-ethyl-6,7-dimethoxy-beta-carboline-3-carboxylate. Yang XM; Luo ZP; Zhou JH J Pharmacol Exp Ther; 1989 Jul; 250(1):358-63. PubMed ID: 2545863 [TBL] [Abstract][Full Text] [Related]
6. Interaction of beta-carboline inverse agonists for the benzodiazepine site with another site on GABAA receptors. Im HK; Im WB; Carter DB; McKinley DD Br J Pharmacol; 1995 Mar; 114(5):1040-4. PubMed ID: 7780638 [TBL] [Abstract][Full Text] [Related]
7. The role of corticotropin-releasing hormone in the dorsal raphe nucleus in mediating the behavioral consequences of uncontrollable stress. Hammack SE; Richey KJ; Schmid MJ; LoPresti ML; Watkins LR; Maier SF J Neurosci; 2002 Feb; 22(3):1020-6. PubMed ID: 11826130 [TBL] [Abstract][Full Text] [Related]
8. The benzodiazepine receptor antagonists flumazenil and CGS8216 block the enhancement of fear conditioning and interference with escape behavior produced by inescapable shock. Maier SF; Grahn RE; Maswood S; Watkins LR Psychopharmacology (Berl); 1995 Sep; 121(2):250-8. PubMed ID: 8545531 [TBL] [Abstract][Full Text] [Related]
9. Role of fear in mediating shuttle escape learning deficit produced by inescapable shock. Maier SF J Exp Psychol Anim Behav Process; 1990 Apr; 16(2):137-49. PubMed ID: 2335769 [TBL] [Abstract][Full Text] [Related]
10. Discriminative stimulus properties of methyl 6,7-dimethoxy-4-ethyl-beta-carboline-3-carboxylate (DMCM), an inverse agonist at benzodiazepine receptors. Nielsen EB; Jepsen SA; Nielsen M; Braestrup C Life Sci; 1985 Jan; 36(1):15-23. PubMed ID: 2981379 [TBL] [Abstract][Full Text] [Related]
11. Impaired escape performance and enhanced conditioned fear in rats following exposure to an uncontrollable stressor are mediated by glutamate and nitric oxide in the dorsal raphe nucleus. Grahn RE; Watkins LR; Maier SF Behav Brain Res; 2000 Jul; 112(1-2):33-41. PubMed ID: 10862933 [TBL] [Abstract][Full Text] [Related]
12. DMCM, a benzodiazepine site inverse agonist, improves active avoidance and motivation in the rat. Samardžić J; Strac DŠ; Obradović M; Oprić D; Obradović DI Behav Brain Res; 2012 Dec; 235(2):195-9. PubMed ID: 22878232 [TBL] [Abstract][Full Text] [Related]
13. The role of the amygdala and dorsal raphe nucleus in mediating the behavioral consequences of inescapable shock. Maier SF; Grahn RE; Kalman BA; Sutton LC; Wiertelak EP; Watkins LR Behav Neurosci; 1993 Apr; 107(2):377-88. PubMed ID: 8484901 [TBL] [Abstract][Full Text] [Related]
14. Discriminative stimulus properties of the benzodiazepine receptor inverse agonist methyl-6,7-dimethoxy-4-ethyl-beta-carboline-3-carboxylate (DMCM). Kirby LG; Rowan GA; Smith RL; Lucki I Psychopharmacology (Berl); 1994 Jan; 113(3-4):351-60. PubMed ID: 7862845 [TBL] [Abstract][Full Text] [Related]
15. Corticotropin releasing hormone type 2 receptors in the dorsal raphe nucleus mediate the behavioral consequences of uncontrollable stress. Hammack SE; Schmid MJ; LoPresti ML; Der-Avakian A; Pellymounter MA; Foster AC; Watkins LR; Maier SF J Neurosci; 2003 Feb; 23(3):1019-25. PubMed ID: 12574432 [TBL] [Abstract][Full Text] [Related]
16. Bidirectional effects of benzodiazepine binding site ligands on active avoidance acquisition and retention: differential antagonism by flumazenil and beta-CCt. Savić MM; Obradović DI; Ugresić ND; Cook JM; Sarma PV; Bokonjić DR Psychopharmacology (Berl); 2005 Jul; 180(3):455-65. PubMed ID: 15719222 [TBL] [Abstract][Full Text] [Related]
17. Blockade of alpha1 adrenoreceptors in the dorsal raphe nucleus prevents enhanced conditioned fear and impaired escape performance following uncontrollable stressor exposure in rats. Grahn RE; Hammack SE; Will MJ; O'Connor KA; Deak T; Sparks PD; Watkins LR; Maier SF Behav Brain Res; 2002 Aug; 134(1-2):387-92. PubMed ID: 12191825 [TBL] [Abstract][Full Text] [Related]
18. Investigating benzodiazepine receptor function in vivo using an intravenous infusion of DMCM. Nutt DJ; Little HJ; Taylor SC; Minchin MC Eur J Pharmacol; 1984 Aug; 103(3-4):359-62. PubMed ID: 6092108 [TBL] [Abstract][Full Text] [Related]
19. Serotonin 1B autoreceptors originating in the caudal dorsal raphe nucleus reduce expression of fear and depression-like behavior. McDevitt RA; Hiroi R; Mackenzie SM; Robin NC; Cohn A; Kim JJ; Neumaier JF Biol Psychiatry; 2011 Apr; 69(8):780-7. PubMed ID: 21353664 [TBL] [Abstract][Full Text] [Related]
20. Opioid-dependent effects of inescapable shock on escape behavior and conditioned fear responding are mediated by the dorsal raphe nucleus. Grahn RE; Maswood S; McQueen MB; Watkins LR; Maier SF Behav Brain Res; 1999 Mar; 99(2):153-67. PubMed ID: 10512582 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]